Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, 7SL, cytoplasmic 339, pseudogene (RN7SL339P)** is a member of a large family of human *7SL RNA pseudogenes*. These are genomic sequences that are highly similar to the functional 7SL RNA gene, but due to accumulated mutations, truncations, or other disruptions, do not code for functional RNA and are generally not transcribed into functional products[1][4]. 7SL RNA pseudogenes like RN7SL339P are evolutionary remnants and generally have no known biological function; they are the byproduct of retrotransposition events where 7SL RNA was copied back into the genome[4]. The canonical 7SL RNA (not the pseudogene) is an integral part of the **signal recognition particle (SRP)**, critical for cotranslational protein targeting; however, *RN7SL339P itself does not fulfill this biological role*[1][3][4]. **Key clarifications:** - RN7SL339P is a pseudogene, not a protein-coding gene or a functional non-coding RNA. - As a pseudogene, it is neither a receptor, enzyme, transporter, nor considered a drug target[1][4]. - Pseudogenes like RN7SL339P are not directly involved in human disease, targeted by drugs, or used as biomarkers. - The correct functional molecule is 7SL RNA (part of SRP), but RN7SL339P is a defunct copy[1][3][4]. - If you are searching for a therapeutic or biological target, RN7SL339P is not appropriate; the confusion may arise from similarity to the functional 7SL RNA gene[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 339, pseudogene (RN7SL339P).